These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18789481)

  • 1. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
    Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
    Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Bergmann F; Breinig M; Höpfner M; Rieker RJ; Fischer L; Köhler C; Esposito I; Kleeff J; Herpel E; Ehemann V; Friess H; Schirmacher P; Kern MA
    Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
    Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
    J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.
    Takao S; Takebayashi Y; Che X; Shinchi H; Natsugoe S; Miyadera K; Yamada Y; Akiyama S; Aikou T
    Clin Cancer Res; 1998 Jul; 4(7):1619-24. PubMed ID: 9676835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer].
    Hua ZM; Li Z; Lou DL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1251-3. PubMed ID: 16939930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas.
    Shimada K; Nara S; Esaki M; Sakamoto Y; Kosuge T; Hiraoka N
    Pancreas; 2011 Apr; 40(3):464-8. PubMed ID: 21289526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma.
    Torer N; Kayaselcuk F; Nursal TZ; Yildirim S; Tarim A; Nòyan T; Karakayali H
    J Surg Oncol; 2007 Oct; 96(5):419-23. PubMed ID: 17874463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
    Srivastava A; Alexander J; Lomakin I; Dayal Y
    Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
    Zhang L; Yuan SZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
    Mitsunaga S; Kinoshita T; Hasebe T; Nakagohri T; Konishi M; Takahashi S; Gotohda N; Ochiai A
    Pancreas; 2008 Apr; 36(3):241-8. PubMed ID: 18362836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy.
    Dalla Valle R; Mancini C; Crafa P; Passalacqua R
    JOP; 2006 Sep; 7(5):473-7. PubMed ID: 16998244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.
    Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ
    Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
    La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
    Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma.
    Takahashi S; Hasebe T; Oda T; Sasaki S; Kinoshita T; Konishi M; Ueda T; Ochiai T; Ochiai A
    Anticancer Res; 2001; 21(2B):1407-12. PubMed ID: 11396223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.